Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center"

Transcription

1 Appropriate Use: Big Brother is Watching Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center

2 Disclosures Consultant Boston Scientific, Medtronic, Middle Peak Medical, Millipede, St Jude Medical

3

4 Cath Lab Banter Is it tight? Looks tight Doesn t look that tight Looks tight in that view Take another view Tight-ish

5 Let s Just Stent It!!

6 Appropriateness

7

8 Appropriateness Caveats a framework for discussion many patients in clinical practice may not be represented uncertain should not be viewed as excluding the use of revascularization for such patients. it is not anticipated that all facilities will have 100% of their revascularization procedures deemed appropriate.

9

10 500,154 PCIs ACC-NCDR Registry JAMA 2011 July 2009 Sept 2010

11 4.1% 11.2% 84.6% Wall Street Journal 2011

12 Clinical Indication (ACS vs. Stable) Angina Severity (CCS Class) Extent of Ischemia Presence of High Risk Features (!EF) Medical Therapy Coronary Anatomy

13 Stress Testing HIGH MEDIUM LOW

14 Canadian Cardiovascular Society Angina Class CCS I CCS II CCS III CCS IV

15 Maximal Medical Therapy At Least 2 Classes of Therapies

16 R4Q Q3 2011

17 2012 Appropriateness Guidelines

18

19 R4Q 2011 Q3

20 icath App

21 SCAI QIT App

22 FFR

23 Fractional Flow Reserve (FFR)

24 Angiography alone cannot determine hemodynamic significance of intermediate stenoses (40-70%) Gross MC, et al. Radiology 2001;220:751.

25 Angiography: Limitations Nissen SE. Cleveland Clinic Journal of Medicine. 66(8):479-85, 1999 Sep

26 Which Coronary Factor is Constant? Pressure, Flow, or Vessel Size? Pressure (mm Hg) APEX Flow (Q) (ml/min) Diameter (mm)

27 Fractional Flow Reserve (FFR) Pa Pd FFR = Pd Pa (mean distal pressure) (mean aortic pressure) In the presence of maximal hyperemia FFR<0.80 ~ ischemia Kern MJ, et al. Circulation 2006;114:1321.

28 St. Jude Volcano PressureWire Aeris 175 and 300 cm lengths Verrata Wire 185 and 300 cm lengths RadiAnalyzer or Quantien ComboMap

29 Pressure Gradients and Hyperemia 65% stenosis Pressure Gradient (mmhg) Normal vessel Velocity (cm/sec) It is important to induce hyperemia to unmask stenosis significance Kern MJ, et al. Circulation 2006;114:1321.

30 Inducing Hyperemia Adenosine Adenosine Route IV IC Dosage 140 mcg/kg/min mcg LCA mcg RCA Time to hyperemia 1 2 min 5-10 sec Advantage Gold Standard Short action Disadvantage BP by 10-15%, Chest burning AV delay, BP

31 FFR Threshold for Ischemia Non-ischemic Range Ischemic Range Significant stenosis Pijls N., De Bruyne B. et al, N Engl J Med 1996; 334(26):

32 FFR vs. Noninvasive Testing FFR 0.75 ETT Thallium ESE Pijls, et al. NEJM 1996;334:1703

33 Non-Ischemic FFR: Generally 0.80 Normalized Wire Pd/Pa = 1.00

34 Ischemic FFR: Generally <0.75

35 FFR If It Isn t Broken, Don t Fix It

36 THE DEFER STUDY: RANDOMIZATION If FFR < 0.75 If FFR > 0.75 performance of PCI reference group (n=144) randomization followed defer PCI (n=91) perform PCI (n=90) Bech. Circulation 2001;103:2928

37 Supporting Clinical Study: DEFER 5Y Follow-Up P< % P< Cardiac Death and Acute MI Rates P= Pijls et De Bruyne, CRT 2007 DEFER PERFORM REFERENCE FFR > 0.75 FFR < 0.75

38 Case FFR mcg/kg/min

39 Case FFR mcg/kg/min

40 FAME N=496 N=509

41 FAME: Freedom from Death, MI, Revasc Fewer stents are better than more stents! FFR-Guided Angio-Guided 730 days 4.5% Pijls. JACC 2010;56.

42

43 Angiography versus FFR in the FAME study Proportions of functionally diseased coronary arteries in patients with angiographic 3 vessel disease 1-VD 34% 3-VD 14% 0-VD 9% 2-VD 43% 3 Vessel Disease P. Tonino et al ESC 2009

44 FAME 2 : FFR-Guided PCI versus Medical Therapy in Stable CAD Flow Chart Stable CAD patients scheduled for 1, 2 or 3 vessel DES-PCI N = 1220 Randomized Trial FFR in all target lesions Registry At least 1 stenosis with FFR 0.80 (n=888) When all FFR > 0.80 (n=332) RandomizaBon 1:1 PCI + MT 73% MT 27% MT 50% randomly assigned to FU Follow-up after 1, 6 months, 1, 2, 3, 4, and 5 years

45 FAME 2 : FFR-Guided PCI versus Medical Therapy in Stable CAD Primary Outcomes Cumulative incidence (%) No. at risk MT PCI+MT Registry PCI+MT vs. MT: HR 0.32 ( ); p<0.001 PCI+MT vs. Registry: HR 1.29 ( ); p=0.61 MT vs. Registry: HR 4.32 ( ); p< Months after randomization

46 FAME 2 : FFR-Guided PCI versus Medical Therapy in Stable CAD Urgent Revascularization Cumulative incidence (%) No. at risk MT PCI+MT Registry PCI+MT vs. MT: MT vs. Registry: HR 0.13 ( ); p<0.001 PCI+MT vs. Registry: HR 0.63 ( ); p=0.43 HR 4.65 ( ); p= Months after randomization

47 FAME 2 : FFR-Guided PCI versus Medical Therapy in Stable CAD Patients with urgent revascularization 21.4% Myocardial Infarction 51.8% 26.8% Unstable angina +evidence of ischemia on ECG

48 Equipoise Aug 28, 2012 Aug 28, 2012

49 2012 Key Elements of Appropriateness For Revascularization in Stable Angina Symptoms consistent with angina Document CCS Class Trial of medical therapy Ischemia documented by stress testing or FFR

50 Clarity? Every Patient is Different

51 Summary Public Reporting of Appropriateness is Here Knowledge of Appropriateness Metrics is Essential FFR is an important tool in the catheterization laboratory for lesion assessment and treatment

52 Thank You

FFR and Acute Coronary Syndromes. William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center

FFR and Acute Coronary Syndromes. William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center FFR and Acute Coronary Syndromes William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Disclosure Statement of Financial Interest Within the past

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Background 8 th Coronary Physiology in the CathLab Course Revascularisation of intermediate stenosis can be targeted EITHER

More information

FFR in the diagnostic phase

FFR in the diagnostic phase FFR in the diagnostic phase Nick Curzen BM(Hons) PHD FRCP Professor of Interventional Cardiology Southampton, UK Conflicts of Interest Unrestricted research funding from: St Jude Medical; Medtronic; Boston

More information

Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm. Invasiv tryckmätning FFR

Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm. Invasiv tryckmätning FFR Namn: Titel: Mattias Törnerud, Capio St Görans sjukhus AB, Stockholm Invasiv tryckmätning FFR Har mo/agit förläsararvoden från St Jude Medical. Intrakoronar tryckmätning, FFR i daglig praxis 1000 angio

More information

FFR CT : Clinical studies

FFR CT : Clinical studies FFR CT : Clinical studies Bjarne Nørgaard Department Cardiology B Aarhus University Hospital Skejby, Denmark Disclosures: Research grants: Edwards and Siemens Coronary CTA: High diagnostic sensitivity

More information

Non-invasive functional testing in 2014

Non-invasive functional testing in 2014 Non-invasive functional testing in 2014 Bjarne Nørgaard Department Cardiology B Aarhus University Hospital Skejby, Disclosures: Research grants: Edwards and Siemens Non-invasive functional testing in 2014

More information

9/15/2015. Functional Assessment of Coronary Artery Stenosis Severity Significance Utility of FFR, IVUS and OCT

9/15/2015. Functional Assessment of Coronary Artery Stenosis Severity Significance Utility of FFR, IVUS and OCT IVUS/OCT = Anatomy vs FFR = Ischemia Functional Assessment of Coronary Artery Stenosis Severity Significance Utility of FFR, IVUS and OCT Morton J. Kern MD, MSCAI, FACC, FAHA Chief of Medicine, VA Long

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions

Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions Non-invasive FFR Using Coronary CT Angiography and Computational Fluid Dynamics Predicts the Hemodynamic Significance of Coronary Lesions Andrejs Erglis, Sanda Jegere, Zanda Runkule, Ligita Zvaigzne, Dace

More information

For the NXT Investigators

For the NXT Investigators Diagnostic performance of non-invasive fractional flow reserve derived from coronary CT angiography in suspected coronary artery disease: The NXT trial Bjarne L. Nørgaard, Jonathon Leipsic, Sara Gaur,

More information

FRACTIONAL FLOW RESERVE CLINICAL STUDY COMMITMENT

FRACTIONAL FLOW RESERVE CLINICAL STUDY COMMITMENT CONTRAST HIGHLIGHTS CONTRAST DATA DEFER HIGHLIGHTS DEFER DATA ABBREVIATIONS FRACTIONAL FLOW RESERVE CLINICAL STUDY COMMITMENT Future 212 215 Past DEFER It is safe to defer non-ischemic stenosis based on

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation. DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

September 2003 Myocardial Perfusion Imaging: a game of acronyms. Mehret Mandefro, Harvard Medical School IV. Gillian Lieberman, MD

September 2003 Myocardial Perfusion Imaging: a game of acronyms. Mehret Mandefro, Harvard Medical School IV. Gillian Lieberman, MD September 2003 Myocardial Perfusion Imaging: a game of acronyms MIBI, Thal, ETT & SPECT Mehret Mandefro, Harvard Medical School IV Objectives Review indications for when myocardial perfusion scans should

More information

Computed tomography coronary angiography in patients with suspected coronary artery disease

Computed tomography coronary angiography in patients with suspected coronary artery disease Computed tomography coronary angiography in patients with suspected coronary artery disease Prof. Dr. Stephen Schröder, EC, FESC Department of Cardiology Klinik am Eichert Göppingen Germany -No conflicts

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Efficient Evaluation of Chest Pain

Efficient Evaluation of Chest Pain Efficient Evaluation of Chest Pain Vikranth Gongidi, DO FACC FACOI Indian River Medical Center Vero Beach, FL No Disclosures Outline Background Chest pain pathway Indications for stress test Stress test

More information

CAAS QCA. The applications and benefits of quantitative coronary angiography

CAAS QCA. The applications and benefits of quantitative coronary angiography CAAS QCA The applications and benefits of quantitative coronary angiography Coronary angiography is routinely used for diagnosis and treatment of millions of patients who have or are at risk of coronary

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Statins: Can there be too much of a good thing?

Statins: Can there be too much of a good thing? Statins: Can there be too much of a good thing? Spoiler alert No Oh Contraire Haaaaiiiiiiile No! Frequently under prescribing statin therapy! Typical Case 68 YO Smoker ACS Multiple prior PCI s Multiple

More information

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469)

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Provider Checklist-Outpatient Imaging Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Medical Review Note: Per InterQual, if any of the following are present,

More information

Contrast Pd/Pa Better than resting measures?

Contrast Pd/Pa Better than resting measures? Contrast Pd/Pa Better than resting measures? Nils P. Johnson, MD, MS, FACC Associate Professor of Medicine Division of Cardiology, Department of Medicine and the Weatherhead PET Imaging Center University

More information

Basic science. Clinical practice CP CP CP

Basic science. Clinical practice CP CP CP What Interventional Cardiology Has Taught Us About Physiology and Pathophysiology 47 th Annual Carl J. Wiggers Memorial Lecture Cleveland, OH David R. Holmes, MD Mayo Clinic Rochester, MN Presenter Disclosure

More information

No conflict of interest

No conflict of interest Anthony Fung Presenter Disclosure The BRIEF-PCI Trial No conflict of interest Brief Infusion of Eptifibatide Following PCI The BRIEF-PCI Trial AY Fung, J Saw, A Starovoytov, C Densem, P Jokhi, SJ Walsh,

More information

Cardiac Stress Testing in Nuclear Cardiology

Cardiac Stress Testing in Nuclear Cardiology Cardiac Stress Testing in Nuclear Cardiology Gaiane Doubinina, RN, MSN, FNP BC Nurse Practitioner, Nuclear Medicine/Cardiac Imaging Learning Objectives: Indications for stress testing Contraindication

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Radiology Rounds A Newsletter for Referring Physicians Massachusetts General Hospital Department of Radiology

Radiology Rounds A Newsletter for Referring Physicians Massachusetts General Hospital Department of Radiology Radiology Rounds A Newsletter for Referring Physicians Massachusetts General Hospital Department of Radiology Nuclear Cardiology Stress Tests for Coronary Artery Disease Exercise ECG without imaging should

More information

Section 8: Clinical Exercise Testing. a maximal GXT?

Section 8: Clinical Exercise Testing. a maximal GXT? Section 8: Clinical Exercise Testing Maximal GXT ACSM Guidelines: Chapter 5 ACSM Manual: Chapter 8 HPHE 4450 Dr. Cheatham Outline What is the purpose of a maximal GXT? Who should have a maximal GXT (and

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

Postoperative Myocardial Infarction: Diagnosis and Management

Postoperative Myocardial Infarction: Diagnosis and Management Postoperative Myocardial Infarction: Diagnosis and Management Todd M. Brown, MD, MSPH Chief Fellow Division of Cardiovascular Diseases December 9, 2008 CHEST PAIN NON-ANGINAL UNSURE ANGINAL STABLE ANGINA

More information

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Ostial LAD: Single stent approach is the best Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI Chair, Interventional Cardiology Sanatorio San Lucas Instituto Alexander Fleming Buenos

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Drug-Eluting Balloons Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam Potential conflicts of interest Speaker s name: Klaus Bonaventura

More information

Effect of Spinal Cord Stimulation on Myocardial Flow Reserve in Patients with Refractory Angina Pectoris

Effect of Spinal Cord Stimulation on Myocardial Flow Reserve in Patients with Refractory Angina Pectoris Effect of Spinal Cord Stimulation on Myocardial Flow Reserve in Patients with Refractory Angina Pectoris Antti Varis, Heikki Ukkonen, Antti Saraste, Tuija Vasankari, Satu Tunturi, Markku Taittonen, Pirkka

More information

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Disclosures Funded by VHA HSR&D Investigator Initiated Award (IIR ) Dr. Bosworth was supported by a VHA HSR&D Senior Scientist Award (08-027) Dr

Disclosures Funded by VHA HSR&D Investigator Initiated Award (IIR ) Dr. Bosworth was supported by a VHA HSR&D Senior Scientist Award (08-027) Dr Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge Ho PM, Lambert-Kerzner A, Carey EP, Fahdi

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

Majestic Trial 12 Month Results

Majestic Trial 12 Month Results Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.

More information

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital

More information

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die

More information

Presenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands

Presenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands Comparing zotarolimus-eluting and bare-metal stent efficacy in selected high bleeding risk patients treated with a short dual antiplatelet therapy duration. A pre-specified analysis from the The Zotarolimuseluting

More information

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical

More information

Rapid Access Chest Pain Clinic to Cath Lab.the journey.. Jenny Deane, Clinical Nurse Specialist, RACPC, RFH

Rapid Access Chest Pain Clinic to Cath Lab.the journey.. Jenny Deane, Clinical Nurse Specialist, RACPC, RFH Rapid Access Chest Pain Clinic to Cath Lab.the journey.. Jenny Deane, Clinical Nurse Specialist, RACPC, RFH Background In the UK: Chest pain is a very common symptom between 20% to 40% of the general population

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:

More information

PROFESSIONAL EDUCATION PROGRAMS 2014 THE KEY ROLES OF EDUCATION

PROFESSIONAL EDUCATION PROGRAMS 2014 THE KEY ROLES OF EDUCATION 603-0500.133.001 PROFESSIONAL EDUCATION PROGRAMS 2014 International Preceptorships Beyond Angio APC Courses London Volcano Intensive Program Angiography is not Enough Proctoring / Peer-to-Peer Congress

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy)

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy) Randomized clinical trial to compare the nephrotoxic effects of iso osmolar vs. low osmolar contrast medium in patients with impaired renal function undergoing PCI CONTRAST (COntrast media and NephroToxicity

More information

Current Challenges in Management of Aortic Stenosis?

Current Challenges in Management of Aortic Stenosis? Current Challenges in Management of Aortic Stenosis? Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital No Relationships

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

LEADERS: 5-Year Follow-up

LEADERS: 5-Year Follow-up LEADERS: -Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable Polymer : Final Report of the LEADERS

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Time to Treatment is critical for STEMI patients For patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Click here for Prescriptive Information.

Click here for Prescriptive Information. Click here for Prescriptive Information. The IVUS that Delivers Confidently! All comparisons are made against the icross /Atlantis SR Pro 2 Coronary Imaging. Measurements taken by Boston Scientific Corporation.

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators Polish-Italian-Hungarian Randomized ThrombEctomy Trial PIHRATE Trial On behalf PIHRATE investigators Dariusz Dudek MD, PhD Institute of Cardiology, Krakow, Poland Impact of distal embolization Distal embolization

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet

MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging Anne Günther Department of Radiology OUS Rikshospitalet CORONARY CT ANGIOGRAPHY (CTA) Accurate method in the assessment of possible

More information

Renal artery stenting: are there any indications left?

Renal artery stenting: are there any indications left? there any indications left? Luís Mendes Pedro, MD. PhD, FEBVS Lisbon Academic Medical Centre (University of Lisbon and Hospital Santa Maria) Instituto Cardiovascular de Lisboa Disclosures Speaker name:

More information

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging Background: Reason: preoperative assessment of CAD, Shortness of Breath Symptom: atypical chest pain Risk factors: hypertension Under influence: a beta blocker Medications: digoxin Height: 66 in. Weight:

More information

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D.

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D. Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel Kiyuk Chang, M.D., Ph.D. Cardiovascular Center & Cardiology Division Seoul St. Mary s Hospital The Catholic University

More information

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot Getting smart about dyspnea and life saving drug therapy in ACS patients Kobi George Kaplan Medical Center Rehovot 78 year old female Case description Presented with resting chest pain and dyspnea Co morbidities:

More information

Databases in Clinical Research. Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support

Databases in Clinical Research. Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support Databases in Clinical Research Harvard-MIT Division of Health Sciences and Technology HST.951J: Medical Decision Support Overview Background: History and utility of clinical data repositories Strategies:

More information

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up Hellenic J Cardiol 45: 379-383, 2004 Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up PETROS S. DARDAS, DIMITRIS

More information

A Comprehensive Strategy for Coordinating the Care for Patients with Coronary Artery Disease (CAD) and Other Chronic Medical Conditions

A Comprehensive Strategy for Coordinating the Care for Patients with Coronary Artery Disease (CAD) and Other Chronic Medical Conditions A Comprehensive Strategy for Coordinating the Care for Patients with Coronary Artery Disease (CAD) and Other Chronic Medical Conditions Presented at the Integrated Healthcare Association Meeting Los Angeles,

More information

The Use of Nuclear Cardiology in Clinical Decision Making. T. Bryson Struse, D.O., F.A.C.O.I., D.A.B.N.M. Carondelet Heart and Vascular Institute

The Use of Nuclear Cardiology in Clinical Decision Making. T. Bryson Struse, D.O., F.A.C.O.I., D.A.B.N.M. Carondelet Heart and Vascular Institute The Use of Nuclear Cardiology in Clinical Decision Making T. Bryson Struse, D.O., F.A.C.O.I., D.A.B.N.M. Carondelet Heart and Vascular Institute Cardiovascular disease remains the leading cause of death

More information

Normal and Abnormal. Heart Rate and Blood Pressure. Signs and Symptoms. Abnormal HR and BP responses. Normal Peak Blood Pressures.

Normal and Abnormal. Heart Rate and Blood Pressure. Signs and Symptoms. Abnormal HR and BP responses. Normal Peak Blood Pressures. Normal and Abnormal Exercise Response Potential Measurements Signs and symptoms Heart rate and blood pressure EKG Cardiac output, stroke volume VO2 Anaerobic threshold O2 pulse Systolic time interval Skin

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

Isabella Sudano & Franco Muggli

Isabella Sudano & Franco Muggli Swiss Hypertension Guidelines Isabella Sudano & Franco Muggli CoLaus, Swisshype ESC 2005 Dokumentenname Datum Seite 1 European Journal of Cardiovascular Prevention and Rehabilitation 2009 Guideline...

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Optical Fiber Sensors for Biomedical Applications

Optical Fiber Sensors for Biomedical Applications Optical Fiber Sensors for Biomedical Applications Xingwei (Vivian) Wang, Ph.D. Assistant Professor Department of Electrical and Computer Engineering University of Massachusetts Lowell Phone: (978) 934-1981

More information

Utilizing the Cath Lab for Cardiac Arrest

Utilizing the Cath Lab for Cardiac Arrest Utilizing the Cath Lab for Cardiac Arrest Khaled M. Ziada, MD Director, Cardiovascular Catheterization Laboratories Gill Heart Institute, University of Kentucky UK/AHA Strive to Revive Symposium May 2013

More information

PCI vs. CABG for Left Main Disease

PCI vs. CABG for Left Main Disease The EXCEL Ti Trial Design, Status, t and Timelines Gregg W. Stone, MD Columbia University Medical Center NewYork-Presbyterian Hospital Cardiovascular Research Foundation PCI vs. CABG for Left Main Disease

More information

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs

Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Needs Paper Number 25 Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Needs Paper Number

More information

Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada

Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada April 2009 Jack V. Tu, MD PhD FRCPC CANADA RESEARCH CHAIR IN HEALTH SERVICES RESEARCH Institute

More information

Cardiac MR Imaging: from Physics to Protocols Case Examples. Disclosures

Cardiac MR Imaging: from Physics to Protocols Case Examples. Disclosures Cardiac MR Imaging: from Physics to Protocols Case Examples David A. Bluemke, M.D., Ph.D. Professor of Radiology and Medicine Clinical Director, MRI Johns Hopkins University School of Medicine Baltimore,

More information

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Stent for Life Initiative How can we improve system delay and patients delay in STEMI Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration

More information

NEW INTERVENTIONAL TECHNOLOGIES

NEW INTERVENTIONAL TECHNOLOGIES by Lawrence M Prescott, PhD NEW INTERVENTIONAL TECHNOLOGIES EXPAND TREATMENT OPTIONS FOR CARDIOVASCULAR DISEASE Novel interventional techniques are proving to be of particular value in the treatment of

More information

Is There a Role for Nuclear Cardiology in the Era of Cardiac CT? E. Gordon DePuey, M.D. Select the Appropriate Test to Meet the Patient Need

Is There a Role for Nuclear Cardiology in the Era of Cardiac CT? E. Gordon DePuey, M.D. Select the Appropriate Test to Meet the Patient Need Is There a Role for Nuclear Cardiology in the Era of Cardiac CT? E. Gordon DePuey, M.D. Clinical Professor of Radiology Icahn School of Medicine at Mt. Sinai Director of Nuclear Medicine Mt. Sinai St.

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

HOW TO INTERPRET THE EXERCISE STRESS TEST. Disclosures: None

HOW TO INTERPRET THE EXERCISE STRESS TEST. Disclosures: None HOW TO INTERPRET THE EXERCISE STRESS TEST Nora Goldschlager, M.D. MACP, FACC, FAHA, FHRS SFGH Division of Cardiology UCSF, San Francisco Disclosures: None ST SEGMENT RESPONSES DURING EXERCISE TESTING:

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park MD PhD Seung-Jung Park, MD, PhD, University of Ulsan

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

The Role of Catheter Ablation in the Management of Ventricular Tachycardia

The Role of Catheter Ablation in the Management of Ventricular Tachycardia The Role of Catheter Ablation in the Management of Ventricular Tachycardia Hugh Calkins M.D. Professor of Medicine Director of Electrophysiology The Johns Hopkins Medical Institutions Cardiology Update

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Role of imaging: Insights from the cardiac catheterization?

Role of imaging: Insights from the cardiac catheterization? History and Clinical Presentation of Hypertrophic Cardiomyopathy Role of imaging: Insights from the cardiac catheterization? Stavros Hadjimiltiades MD, FACC, FACP Associate Professor in Cardiology Focal

More information

Implementing a Prehospital 12-Lead Program

Implementing a Prehospital 12-Lead Program Implementing a Prehospital 12-Lead Program Corey M. Slovis, M.D. Professor and Chairman Department of Emergency Medicine Vanderbilt University Medical Center Medical Director, Metro Nashville Fire Department

More information

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Recommendations of the European Society of Cardiology Updated version December 2002 Task Force on management

More information